Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
After nearly four decades of research, a safe and effective HIV-1 vaccine remains elusive. There are many reasons why the development of a potent and durable HIV-1 vaccine is challenging, including the extraordinary genetic diversity of HIV-1 and its complex mechanisms of immune evasion. HIV-1 envel...
Main Authors: | Haynes, BF, Wiehe, K, Borrow, P, Saunders, KO, Korber, B, Wagh, K, McMichael, AJ, Kelsoe, G, Hahn, BH, Alt, F, Shaw, GM |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer Nature
2022
|
Similar Items
-
Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies
by: Garnett Kelsoe, et al.
Published: (2013-12-01) -
HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development.
by: Laurent Verkoczy, et al.
Published: (2014-05-01) -
Immune perturbations in HIV-1–infected individuals who make broadly neutralizing antibodies
by: Moody, M, et al.
Published: (2016) -
P04-26. Immunological tolerance prevents the expression of a broadly reactive neutralizing HIV-1 antibody
by: Kelsoe G, et al.
Published: (2009-10-01) -
HIV-host interactions: implications for vaccine design
by: Haynes, B, et al.
Published: (2016)